Jpmorgan Chase & CO Integra Lifesciences Holdings Corp Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 106,909 shares of IART stock, worth $2.58 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
106,909
Previous 152,881
30.07%
Holding current value
$2.58 Million
Previous $5.42 Million
42.52%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding IART
# of Institutions
241Shares Held
74.8MCall Options Held
10.7KPut Options Held
57.7K-
Black Rock Inc. New York, NY11.3MShares$271 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.77MShares$187 Million0.0% of portfolio
-
Morgan Stanley New York, NY5.5MShares$133 Million0.01% of portfolio
-
Eaton Vance Management Boston, MA4.22MShares$102 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA3.89MShares$93.7 Million0.02% of portfolio
About INTEGRA LIFESCIENCES HOLDINGS CORP
- Ticker IART
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 83,518,200
- Market Cap $2.01B
- Description
- Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...